Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
2.
Clin. transl. oncol. (Print) ; 17(11): 884-887, nov. 2015. graf
Article in English | IBECS | ID: ibc-143459

ABSTRACT

Introduction. Autologous tumor cell vaccines rely on the concept of preserving an individual’s own tumorigenic makeup, expressing its unique set of tumor-associated antigens as well as antigenic elements from the surrounding stroma. These autologous tumor characteristics are usually presented with an immune adjuvant in the hopes of enhancing an immune response. Methods. The autologous vaccine we used was composed of tumor cells combined with BCG and formalin. Animal safety and toxicity were evaluated using mice tumors for the immunotherapy. A small number of patients with advanced stage breast cancer were recruited for an uncontrolled study, using the vaccine solely or combined with chemotherapy/radiotherapy. Results. The immunotherapy had shown to be safe in mice and humans. Upon a 5-year follow-up, the survival rate was 60 % for the combined treatment. Conclusions. The data suggest that the combined treatment could be a feasible and safe therapeutic strategy. However, further controlled studies should be conducted (AU)


No disponible


Subject(s)
Adult , Animals , Female , Humans , Mice , Autoantigens , Immunotherapy/instrumentation , Immunotherapy/trends , Immunotherapy , Mycobacterium bovis/isolation & purification , BCG Vaccine/immunology , BCG Vaccine/therapeutic use , Breast Neoplasms/diagnosis , Breast Neoplasms/immunology , Immunotherapy/methods , Immunotherapy/standards , Breast Neoplasms/drug therapy , Breast Neoplasms/radiotherapy , Chemotherapy, Adjuvant/methods , Chemotherapy, Adjuvant/veterinary , Radiotherapy, Adjuvant/methods , Radiotherapy, Adjuvant/veterinary , Chemoradiotherapy, Adjuvant/veterinary
3.
Clin Transl Oncol ; 17(11): 884-7, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26077120

ABSTRACT

INTRODUCTION: Autologous tumor cell vaccines rely on the concept of preserving an individual's own tumorigenic makeup, expressing its unique set of tumor-associated antigens as well as antigenic elements from the surrounding stroma. These autologous tumor characteristics are usually presented with an immune adjuvant in the hopes of enhancing an immune response. METHODS: The autologous vaccine we used was composed of tumor cells combined with BCG and formalin. Animal safety and toxicity were evaluated using mice tumors for the immunotherapy. A small number of patients with advanced stage breast cancer were recruited for an uncontrolled study, using the vaccine solely or combined with chemotherapy/radiotherapy. RESULTS: The immunotherapy had shown to be safe in mice and humans. Upon a 5-year follow-up, the survival rate was 60 % for the combined treatment. CONCLUSIONS: The data suggest that the combined treatment could be a feasible and safe therapeutic strategy. However, further controlled studies should be conducted.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Breast Neoplasms/therapy , Cancer Vaccines/therapeutic use , Mycobacterium bovis/immunology , Animals , Antineoplastic Agents/therapeutic use , Breast Neoplasms/mortality , Cancer Vaccines/immunology , Chemoradiotherapy , Cricetinae , Female , Guinea Pigs , Humans , Mice , Mice, Inbred BALB C , Survival Rate
4.
Int J Hypertens ; 2013: 329602, 2013.
Article in English | MEDLINE | ID: mdl-23984047

ABSTRACT

We examined 33 hypertensive (22 with comorbid type 2 diabetes mellitus (T2DM)) and 29 normotensive (8 with T2DM) middle-aged and elderly adults, comparable in age and education. Relative to normotensive participants, those with hypertension, in addition to a higher prevalence of periventricular white matter (WM) lesions, had significantly lower WM microstructural integrity of major fiber tracts as seen with MRI-based diffusion tensor imaging. Among participants with hypertension, those with co-morbid T2DM (n = 22) had more widespread WM pathology than those without T2DM (n = 11). Furthermore and consistent with previous research, both hypertension and T2DM were related to decreased retinal arterial diameter. Further exploratory analysis demonstrated that the observed retinal arteriolar narrowing among individual with hypertension was associated with widespread subclinical losses in WM microstructural integrity and these associations were present predominantly in the frontal lobe. We found that T2DM adds to the damaging effects of hypertension on cerebral WM, and notably these effects were independent of age and body mass index. Given that the decrease in retinal arteriolar diameter may be a biomarker for parallel pathology in cerebral arterioles, our data suggest that the frontal lobe may be particularly vulnerable to microvascular damage in the presence of hypertension and T2DM.

5.
AJNR Am J Neuroradiol ; 32(11): 2037-42, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21960489

ABSTRACT

BACKGROUND AND PURPOSE: Emerging evidence suggests that obese adolescents show changes in brain structure compared with lean adolescents. In addition, obesity impacts body development during adolescence. We tested a hypothesis that T1, a marker of brain maturation, can show brain differences associated with obesity. MATERIALS AND METHODS: Adolescents similar in sex, family income, and school grade were recruited by using strict entry criteria. We measured brain T1 in 48 obese and 31 lean adolescents by quantitative MR imaging at 1.5T. We combined MPRAGE and inversion-recovery sequences with normalization to standard space and automated skull stripping to obtain T1 maps with a symmetric voxel volume of 1 mm(3). RESULTS: Sex, income, triglycerides, total cholesterol, and fasting glucose did not differ between groups, but obese adolescents had significantly lower HDL, higher LDL, and higher fasting insulin levels than lean adolescents. Intracranial vault volume did not differ between groups, but obese adolescents had smaller intracranial vault-adjusted brain parenchymal volumes. Obese adolescents had 4 clusters (>100 contiguous voxels) of T1 relaxation that were significantly different (P < .005) from those in lean adolescents. Three of these clusters had longer T1s in obese adolescents (in the orbitofrontal and parietal regions), and 1 cluster had shorter T1s, compared with lean adolescents. CONCLUSIONS: Our results suggest that obesity may have a significant impact on brain development, especially in the frontal and parietal lobes. It is unclear if these changes persist into adulthood or whether they indicate that obese subjects follow a different developmental trajectory during adolescence.


Subject(s)
Brain/pathology , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Obesity/pathology , Thinness/pathology , Adolescent , Adult , Female , Humans , Male , Organ Size , Reproducibility of Results , Sensitivity and Specificity , Young Adult
6.
Neuroradiol J ; 24(6): 854-61, 2011 Dec 30.
Article in English | MEDLINE | ID: mdl-24059886

ABSTRACT

The brain is the most cholesterol-rich organ in the body. Although most of the cholesterol in the brain is produced endogenously, some studies suggest that systemic cholesterol may be able to enter the brain. We investigated whether abnormal cholesterol profiles correlated with diffusion-tensor-imaging-based estimates of white matter microstructural integrity of lean and overweight/obese (o/o) adults. Twenty-two lean and 39 obese adults underwent magnetic resonance imaging, kept a three-day food diary, and had a standardized assessment of fasting blood lipids. The lean group ate less cholesterol-rich food than o/o although both groups ate equivalent servings of food per day. Voxelwise correlational analyses controlling for age, diabetes, and white matter hyperintensities, resulted in two significant clusters of negative associations between abnormal cholesterol profile and fractional anisotropy, located in the left and right prefrontal lobes. When the groups were split, the lean subjects showed no associations, whereas the o/o group expanded the association to three significant clusters, still in the frontal lobes. These findings suggest that cholesterol profile abnormalities may explain some of the reductions in white matter microstructural integrity that are reported in obesity.

7.
Diabetologia ; 53(11): 2298-306, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20668831

ABSTRACT

AIMS/HYPOTHESIS: Central nervous system abnormalities, including cognitive and brain impairments, have been documented in adults with type 2 diabetes who also have multiple co-morbid disorders that could contribute to these observations. Assessing adolescents with type 2 diabetes will allow the evaluation of whether diabetes per se may adversely affect brain function and structure years before clinically significant vascular disease develops. METHODS: Eighteen obese adolescents with type 2 diabetes and 18 obese controls without evidence of marked insulin resistance, matched on age, sex, school grade, ethnicity, socioeconomic status, body mass index and waist circumference, completed MRI and neuropsychological evaluations. RESULTS: Adolescents with type 2 diabetes performed consistently worse in all cognitive domains assessed, with the difference reaching statistical significance for estimated intellectual functioning, verbal memory and psychomotor efficiency. There were statistical trends for executive function, reading and spelling. MRI-based automated brain structural analyses revealed both reduced white matter volume and enlarged cerebrospinal fluid space in the whole brain and the frontal lobe in particular, but there was no obvious grey matter volume reduction. In addition, assessments using diffusion tensor imaging revealed reduced white and grey matter microstructural integrity. CONCLUSIONS/INTERPRETATION: This is the first report documenting possible brain abnormalities among obese adolescents with type 2 diabetes relative to obese adolescent controls. These abnormalities are not likely to result from education or socioeconomic bias and may result from a combination of subtle vascular changes, glucose and lipid metabolism abnormalities and subtle differences in adiposity in the absence of clinically significant vascular disease. Future efforts are needed to elucidate the underlying pathophysiological mechanisms.


Subject(s)
Brain/pathology , Diabetes Mellitus, Type 2/complications , Obesity/complications , Adolescent , Body Mass Index , Female , Humans , Magnetic Resonance Imaging , Male , Neuropsychological Tests , Waist Circumference
8.
J Clin Exp Neuropsychol ; 32(5): 487-93, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20524222

ABSTRACT

To determine whether the cognitive impairments observed in adults with type 2 diabetes mellitus (T2DM) exist in preclinical disease, we compared 38 adult participants with evidence of insulin resistance (IR) to 54 age-, gender-, and education-matched control participants on a battery of neuropsychological tests. We found that participants with IR had performance reductions in declarative memory and executive functioning. When we examined IR simultaneously with other biomedical indicators with which it co-occurs, only IR itself was associated with declarative memory, and hemoglobin A1c (HbA1c) was associated with executive functioning and working memory. We conclude that individuals with insulin resistance already demonstrate similar reductions in cognitive performance as those described in T2DM.


Subject(s)
Aging , Cognition Disorders/physiopathology , Insulin Resistance , Age Factors , Aged , Blood Glucose/metabolism , Case-Control Studies , Executive Function/physiology , Female , Glycated Hemoglobin/metabolism , Humans , Insulin Resistance/physiology , Male , Memory/physiology , Middle Aged , Neuropsychological Tests , Sex Factors
9.
Inflammation ; 31(3): 198-207, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18347963

ABSTRACT

Our objective was to ascertain the nature of the associations between C-reactive protein (CRP) and cognition, and to examine how they are affected by gender and obesity. We evaluated 62 females and 63 males between 42 and 82 years of age. There were 20 lean females with a body mass index (BMI) of <25 kg/m2 and 42 overweight or obese females, with BMIs > or =25 kg/m2. There were 14 lean males and 49 with BMIs >/=25 kg/m2. CRP was associated with lower scores on cognitive tests of frontal lobe function among females and these associations were driven by the overweight/obese female group. In these data no associations between CRP and cognition were found among males. Obesity-associated inflammation is much more prominent in females and it appears to be associated with cognitive dysfunction, particularly of frontal lobe tasks.


Subject(s)
C-Reactive Protein/metabolism , Cognition , Inflammation/blood , Obesity/blood , Overweight/blood , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Body Mass Index , Female , Humans , Inflammation/etiology , Inflammation/psychology , Male , Middle Aged , Obesity/complications , Obesity/psychology , Overweight/complications , Overweight/psychology , Sex Factors
10.
Diabetologia ; 50(4): 711-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17334649

ABSTRACT

AIMS/HYPOTHESIS: There is evidence that type 2 diabetes mellitus is associated with cognitive impairment. Most studies investigating this association have evaluated elderly individuals, after many years of diabetes, who generally have poor glycaemic control and significant vascular disease. The aim of the current study was to investigate the early cognitive consequences and associated brain correlates of type 2 diabetes. MATERIALS AND METHODS: With regard to cognition and brain measures, we compared 23 age-, sex- and education-matched control subjects with 23 mostly middle-aged individuals with relatively well-controlled diabetes of less than 10 years from the time of diagnosis. RESULTS: We found deficits in hippocampal-based memory performance and preservation of other cognitive domains. Relative to control subjects, individuals with diabetes had reductions in brain volumes that were restricted to the hippocampus. There was an inverse relationship between glycaemic control and hippocampal volume; in multivariate regression analysis, HbA(1c) was the only significant predictor of hippocampal volume, accounting for 33% of the observed variance. Other variables commonly associated with type 2 diabetes, such as elevated BMI, hypertension or dyslipidaemia, did not independently contribute to the variance in hippocampal volume. CONCLUSIONS/INTERPRETATION: These results suggest that the medial temporal lobe may be the first brain site affected by type 2 diabetes and that individuals in poorer metabolic control may be affected to a greater extent.


Subject(s)
Brain Diseases/complications , Diabetes Complications/diagnosis , Diabetes Mellitus, Type 2/pathology , Hippocampus/pathology , Memory Disorders/complications , Aged , Brain/pathology , Cognition , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neuropsychological Tests
11.
Neurology ; 64(11): 1860-7, 2005 Jun 14.
Article in English | MEDLINE | ID: mdl-15955934

ABSTRACT

BACKGROUND: To facilitate image analysis, most recent 2-[18F]fluoro-2-deoxy-d-glucose PET (FDG-PET) studies of glucose metabolism (MRglc) have used automated voxel-based analysis (VBA) procedures but paradoxically none reports hippocampus MRglc reductions in mild cognitive impairment (MCI) or Alzheimer disease (AD). Only a few studies, those using regions of interest (ROIs), report hippocampal reductions. The authors created an automated and anatomically valid mask technique to sample the hippocampus on PET (HipMask). METHODS: Hippocampal ROIs drawn on the MRI of 48 subjects (20 healthy elderly [NL], 16 MCI, and 12 AD) were used to develop the HipMask. The HipMask technique was applied in an FDG-PET study of NL (n = 11), MCI (n = 13), and AD (n = 12), and compared to both MRI-guided ROIs and VBA methods. RESULTS: HipMask and ROI hippocampal sampling produced significant and equivalent MRglc reductions for contrasts between MCI and AD relative to NL. The VBA showed typical cortical effects but failed to show hippocampal MRglc reductions in either clinical group. Hippocampal MRglc was the only discriminator of NL vs MCI (78% accuracy) and added to the cortical MRglc in classifying NL vs AD and MCI vs AD. CONCLUSIONS: The new HipMask technique provides accurate and rapid assessment of the hippocampus on PET without the use of regions of interest. Hippocampal glucose metabolism reductions are found in both mild cognitive impairment and Alzheimer disease and contribute to their diagnostic classification. These results suggest re-examination of prior voxel-based analysis 2-[18F]fluoro-2-deoxy-d-glucose PET studies that failed to report hippocampal effects.


Subject(s)
Alzheimer Disease/diagnosis , Cognition Disorders/diagnosis , Fluorodeoxyglucose F18 , Hippocampus/metabolism , Image Processing, Computer-Assisted/methods , Positron-Emission Tomography/methods , Aged , Aged, 80 and over , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/metabolism , Cognition Disorders/diagnostic imaging , Cognition Disorders/metabolism , Cohort Studies , Down-Regulation/physiology , Energy Metabolism/physiology , Female , Glucose/metabolism , Hippocampus/diagnostic imaging , Hippocampus/physiopathology , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Predictive Value of Tests , Reproducibility of Results , Software Design
12.
Neurology ; 63(12): 2354-9, 2004 Dec 28.
Article in English | MEDLINE | ID: mdl-15623699

ABSTRACT

OBJECTIVE: To establish the progression of brain atrophy rates in patients with a known date of onset of Alzheimer disease (AD). METHODS: Each of 18 subjects had two high-resolution T1-weighted three-dimensional MRI examinations. The two MRIs were coregistered and the annual rate of brain tissue atrophy was derived both for the entire brain and regionally for the left and right medial temporal lobe (MTL). Time since onset (TSO) of AD, defined as the interval between the date of onset and the midpoint of MRI dates, ranged from -2.9 to 4.2 years. RESULTS: In patients with AD, TSO was a correlate of the atrophy rate for both the left MTL (R2 = 0.58, p = 0.001) and right MTL (R2 = 0.30, p = 0.03). When serial measurements were applied to a control group of 21 cognitively normal elderly subjects, MTL atrophy rate classified the group membership (AD vs normal cognition) with an accuracy of 92.3%. CONCLUSION: Increased annual atrophy rate in the medial temporal lobe is a potential diagnostic marker of the progression of Alzheimer disease.


Subject(s)
Alzheimer Disease/pathology , Temporal Lobe/pathology , Aged , Aged, 80 and over , Alzheimer Disease/diagnosis , Atrophy , Disease Progression , Female , Follow-Up Studies , Humans , Imaging, Three-Dimensional , Magnetic Resonance Imaging , Male , Neuropsychological Tests
13.
Neurosci Lett ; 333(3): 183-6, 2002 Nov 29.
Article in English | MEDLINE | ID: mdl-12429378

ABSTRACT

Cross-sectional cerebrospinal fluid (CSF) levels of tau and amyloid (A) beta (beta) are of diagnostic importance for Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, most longitudinal studies of tau fail to demonstrate progression. Because predominantly brain-derived proteins such as tau, have higher ventricle to lumbar ratios, we hypothesized that adjusting for the ventricular enlargement of AD would correct for the dilution of tau, and improve detection of longitudinal change. Abeta which is not exclusively brain derived, shows a ratio <1, and no benefit was expected from adjustment. In a 1 year longitudinal study of eight MCI and ten controls, we examined CSF levels of hyperphosphorylated (P) tau231, Abeta40, and Abeta42. In cross-section, MCI patients showed elevated Ptau231 and Abeta40 levels, and greater ventricular volumes. Longitudinally, only after adjusting for the ventricular volume and only for Ptau231, were increases seen in MCI. Further studies are warranted on mechanisms of tau clearance and on using imaging to interpret CSF studies.


Subject(s)
Amyloid beta-Peptides/cerebrospinal fluid , Cognition Disorders/cerebrospinal fluid , tau Proteins/cerebrospinal fluid , Aged , Biomarkers , Cognition Disorders/diagnosis , Cognition Disorders/psychology , Cross-Sectional Studies , Enzyme-Linked Immunosorbent Assay/methods , Female , Follow-Up Studies , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Male , Middle Aged , Peptide Fragments/cerebrospinal fluid , Reference Values , Severity of Illness Index , Statistics, Nonparametric
14.
Behav Neurosci ; 115(5): 1002-11, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11584913

ABSTRACT

Nine young and 11 elderly men participated in this placebo-controlled, double-blind, crossover study (0.5 mg/kg cortisol or intravenous placebo). Participants learned a word list before cortisol administration, and delayed recall was then tested. A 2nd word list was learned and recalled after drug administration. In addition, the Paragraph Recall Test and tests measuring working memory (Digit Span), attention (timed cancellation), and response inhibition (Stroop Color and Word Test) were administered at 2 time points after drug administration. Cortisol reduced recall from the word list learned before treatment in both groups but did not influence recall of the list learned after treatment. In contrast, Digit Span performance was decreased by cortisol in young but not elderly participants. The possibility that differential age-associated brain changes might underlie the present results is discussed.


Subject(s)
Hydrocortisone/analogs & derivatives , Hydrocortisone/pharmacology , Mental Recall/drug effects , Verbal Learning/drug effects , Adult , Age Factors , Aged , Attention/drug effects , Cross-Over Studies , Discrimination Learning/drug effects , Double-Blind Method , Humans , Male , Middle Aged , Neuropsychological Tests , Problem Solving/drug effects , Retention, Psychology/drug effects , Serial Learning/drug effects
15.
Psychiatry Res ; 107(2): 61-73, 2001 Aug 25.
Article in English | MEDLINE | ID: mdl-11530273

ABSTRACT

Frontal lobe dysfunction is thought to be involved in schizophrenia and age-associated cognitive decline. Frontal lobe volume changes have been investigated in these conditions using MRI, but results have been inconsistent. Few volumetric MRI protocols exist that divide the pre-frontal cortex into its sub-regions. In the present article, we describe a new method, which allows assessment of the superior, middle and inferior frontal gyrus, as well as the orbitofrontal and cingulate regions. The method uses multiple planes to help guide the anatomical decisions and combines this with a geometric approach utilizing readily apparent anatomical landmarks. Using this protocol, the frontal lobe volumes in young healthy subjects were contrasted with those of young schizophrenic patients and elderly healthy subjects (nine male subjects per group). The results showed that the method could be reproduced with high reliability (r(icc)> or =0.88-0.99). Schizophrenic as well as old subjects had specific significant reductions in the superior frontal gyrus and orbitofrontal regions compared with the young group. However, old and schizophrenic subjects did not differ from each another. No volume differences were observed in the other three regions assessed. Whether or not these volume reductions reflect a common pathological process remains to be investigated in future studies.


Subject(s)
Aging/physiology , Prefrontal Cortex/pathology , Prefrontal Cortex/physiopathology , Schizophrenia/diagnosis , Schizophrenia/physiopathology , Adult , Aged , Cognition Disorders/diagnosis , Female , Humans , Magnetic Resonance Imaging , Male , Neuropsychological Tests
16.
Proc Natl Acad Sci U S A ; 98(19): 10966-71, 2001 Sep 11.
Article in English | MEDLINE | ID: mdl-11526211

ABSTRACT

Neuropathology studies show that patients with mild cognitive impairment (MCI) and Alzheimer's disease typically have lesions of the entorhinal cortex (EC), hippocampus (Hip), and temporal neocortex. Related observations with in vivo imaging have enabled the prediction of dementia from MCI. Although individuals with normal cognition may have focal EC lesions, this anatomy has not been studied as a predictor of cognitive decline and brain change. The objective of this MRI-guided 2-[(18)F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) study was to examine the hypothesis that among normal elderly subjects, EC METglu reductions predict decline and the involvement of the Hip and neocortex. In a 3-year longitudinal study of 48 healthy normal elderly, 12 individuals (mean age 72) demonstrated cognitive decline (11 to MCI and 1 to Alzheimer's disease). Nondeclining controls were matched on apolipoprotein E genotype, age, education, and gender. At baseline, metabolic reductions in the EC accurately predicted the conversion from normal to MCI. Among those who declined, the baseline EC predicted longitudinal memory and temporal neocortex metabolic reductions. At follow-up, those who declined showed memory impairment and hypometabolism in temporal lobe neocortex and Hip. Among those subjects who declined, apolipoprotein E E4 carriers showed marked longitudinal temporal neocortex reductions. In summary, these data suggest that an EC stage of brain involvement can be detected in normal elderly that predicts future cognitive and brain metabolism reductions. Progressive E4-related hypometabolism may underlie the known increased susceptibility for dementia. Further study is required to estimate individual risks and to determine the physiologic basis for METglu changes detected while cognition is normal.


Subject(s)
Brain/diagnostic imaging , Cognition Disorders/diagnostic imaging , Aged , Aged, 80 and over , Apolipoproteins E/metabolism , Cognition Disorders/metabolism , Entorhinal Cortex/diagnostic imaging , Female , Fluorodeoxyglucose F18/metabolism , Follow-Up Studies , Hippocampus/diagnostic imaging , Humans , Longitudinal Studies , Magnetic Resonance Imaging/methods , Male , Middle Aged , Predictive Value of Tests , Radiography , Tomography, Emission-Computed/methods
17.
Neurobiol Aging ; 22(4): 529-39, 2001.
Article in English | MEDLINE | ID: mdl-11445252

ABSTRACT

We used MRI volume sampling with coregistered and atrophy corrected FDG-PET scans to test three hypotheses: 1) hippocampal formation measures are superior to temporal neocortical measures in the discrimination of normal (NL) and mild cognitive impairment (MCI); 2) neocortical measures are most useful in the separation of Alzheimer disease (AD) from NL or MCI; 3) measures of PET glucose metabolism (MRglu) have greater diagnostic sensitivity than MRI volume. Three groups of age, education, and gender matched NL, MCI, and AD subjects were studied. The results supported the hypotheses: 1) entorhinal cortex MRglu and hippocampal volume were most accurate in classifying NL and MCI; 2) both imaging modalities identified the temporal neocortex as best separating MCI and AD, whereas widespread changes accurately classified NL and AD; 3) In most between group comparisons regional MRglu measures were diagnostically superior to volume measures. These cross-sectional data show that in MCI hippocampal formation changes exist without significant neocortical changes. Neocortical changes best characterize AD. In both MCI and AD, metabolism reductions exceed volume losses.


Subject(s)
Alzheimer Disease/pathology , Cognition Disorders/pathology , Glucose/metabolism , Hippocampus/metabolism , Hippocampus/pathology , Aged , Aged, 80 and over , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/metabolism , Atrophy , Cognition Disorders/diagnostic imaging , Cognition Disorders/metabolism , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Predictive Value of Tests , Sensitivity and Specificity , Tomography, Emission-Computed
19.
Neurobiol Aging ; 21(1): 19-26, 2000.
Article in English | MEDLINE | ID: mdl-10794844

ABSTRACT

Our goal was to ascertain, among normal elderly and individuals with mild cognitive impairment, which temporal lobe neocortical regions predicted decline to dementia of the Alzheimer's type (DAT). Individuals received an MRI at baseline and a clinical and cognitive evaluation at baseline and follow-up. By using the baseline MRI we assessed the anatomical subdivisions of the temporal lobe: anteromedial temporal lobe (hippocampus and parahippocampal gyrus), medial occipitotemporal (fusiform) gyrus, middle and inferior temporal gyri, and superior temporal gyrus. We studied two groups of carefully screened age- and education-matched elderly individuals: 26 normal elderly (NL) and 20 individuals with mild cognitive impairment (MCI). Fourteen individuals (12 from the MCI group and two from the NL group) declined to DAT within the 3.2-year follow-up interval. We used logistic regression analyses to ascertain whether the baseline brain volumes were useful predictors of decline to DAT at follow-up after accounting for age, gender, individual differences in brain size, and other variables known to predict DAT. After accounting for age, gender, and head size, adding the volume of the anteromedial temporal lobe (the aggregate of hippocampus and parahippocampal gyrus) and an index of global atrophy raised the accuracy of overall classification to 80.4%. However, the ability to detect those individuals who declined (sensitivity) was low at 57%. When baseline medial occipitotemporal and the combined middle and inferior temporal gyri were added to the logistic model, the overall classification accuracy reached 95.6% and, most importantly, the sensitivity rose to 92.8%. These data indicate that the medial occipitotemporal and the combined middle and inferior temporal gyri may be the first temporal lobe neocortical sites affected in AD; atrophy in these areas may herald the presence of future AD among nondemented individuals. No other clinical baseline variables examined predicted decline with sensitivities above 71%. The apolipoprotein APOE epsilon4 genotype was not associated with decline.


Subject(s)
Alzheimer Disease/diagnosis , Hippocampus/pathology , Parahippocampal Gyrus/pathology , Temporal Lobe/pathology , Age Factors , Aged , Alzheimer Disease/complications , Alzheimer Disease/pathology , Atrophy/etiology , Atrophy/pathology , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Multivariate Analysis , Neuropsychological Tests , Severity of Illness Index , Sex Factors
20.
Neuroscience ; 95(3): 721-5, 2000.
Article in English | MEDLINE | ID: mdl-10670438

ABSTRACT

For 11 AD cases and four normal elderly controls, post mortem volumes of the hippocampal subdivisions were calculated by using magnetic resonance imaging and histological sections. After at least six weeks of fixation in formalin, brains were examined on a 1.5-T Philips Gyroscan imager producing T1-weighted coronal images with a 3-mm slice thickness. Brains were then processed and embedded in paraffin. Serial coronal sections, 3 mm apart and stained with Cresyl Violet, were used for the planimetry and unbiased estimation of the total numbers of neurons in the hippocampal subdivisions. For all 15 cases, magnetic resonance imaging- and histology-based measurements were performed along the whole rostrocaudal extent of the hippocampal formation and included three subvolumes: (i) the hippocampus (CA1-CA4 and the dentate gyrus); (ii) hippocampus/subiculum; and (iii) hippocampus/parahippocampal gyrus. After controlling for shrinkage, strong correlations were found between magnetic resonance imaging and histological measurements for the hippocampus (r = 0.97, P < 0.001), hippocampus/subiculum (r = 0.95, P < 0.001) and hippocampus/parahippocampal gyrus (r = 0.89, P < 0.001). We also calculated the total number of neurons in the hippocampus and hippocampus/subiculum subvolumes. Strong correlations between the magnetic resonance imaging subvolumes and neuronal counts were found for the hippocampus (r = 0.90, P < 0.001) and the hippocampus/subiculum subvolume (r = 0.84, P < 0.001). We conclude that very accurate volumetric measurements of the whole hippocampal formation can be obtained by using a magnetic resonance imaging protocol. Moreover, the strong correlations between magnetic resonance imaging-based hippocampal volumes and neuronal numbers suggest the anatomical validity of magnetic resonance imaging volume measurements.


Subject(s)
Alzheimer Disease/pathology , Hippocampus/pathology , Magnetic Resonance Imaging , Aged , Cadaver , Cell Count , Humans , Neurons/pathology , Parahippocampal Gyrus/pathology , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...